Filed before 2025Filed 12 October 2021
1859, Inc. raised $2M
1859, Inc., a biotech company based in San Diego, CA, raised $2M in a new debt round, according to a filing dated 12 October 2021.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 12 October 2021
- Round
- Debt round
- Amount sold
- $2M
- Offering size
- $2M
- Investors so far
- 3
- Based in
- San Diego, CA
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
2 directors of this company are named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 14% of the 2,220 tracked raises with an amount filed in 2021, and than 14% of the 177 in biotech.
1859, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 19 Nov 2021 | New filing | $40M | Another raise |
| 12 Oct 2021 | New filing | $2M | This raise |
| 16 Sep 2021 | Amended filing | $9.71M | Another raise |
| 25 Aug 2020 | New filing | $7.71M | Another raise |
| 8 Jul 2019 | New filing | $500K | Another raise |
More with General Inception on the board
- SimBioSys, Inc.$5.25M
- Switchback Systems, Inc.$11.3M
- Alida Biosciences Inc.$7.52M
- Glyphic Biotechnologies, Inc.$33.2M
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.